INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,138 | -6.2% | 289 | +20.9% | 0.00% | – |
| Q2 2023 | $9,746 | -9.2% | 239 | -17.0% | 0.00% | – |
| Q1 2023 | $10,734 | +76.8% | 288 | +65.5% | 0.00% | – |
| Q4 2022 | $6,071 | -39.3% | 174 | -2.2% | 0.00% | – |
| Q3 2022 | $10,000 | +11.1% | 178 | +0.6% | 0.00% | – |
| Q2 2022 | $9,000 | -35.7% | 177 | -11.5% | 0.00% | -100.0% |
| Q1 2022 | $14,000 | -41.7% | 200 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $24,000 | -33.3% | 199 | -24.9% | 0.00% | 0.0% |
| Q3 2021 | $36,000 | +80.0% | 265 | +113.7% | 0.00% | 0.0% |
| Q2 2021 | $20,000 | +66.7% | 124 | -17.3% | 0.00% | 0.0% |
| Q1 2021 | $12,000 | +500.0% | 150 | +328.6% | 0.00% | – |
| Q4 2020 | $2,000 | -90.0% | 35 | -96.5% | 0.00% | -100.0% |
| Q3 2017 | $20,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |